Detalhe da pesquisa
1.
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study.
Cephalalgia
; 41(13): 1285-1297, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34171973